New surgery technique could improve survival in recurrent throat cancer

NCT ID NCT04425265

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares two surgical techniques for treating nasopharyngeal cancer that has come back after radiation. 500 participants will be randomly assigned to receive either low-temperature plasma ablation or high-frequency electrocautery. The goal is to see which method leads to better survival without the cancer returning.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Plasma radiofrequency ablation (low-temperature) and electrocautery block resection (high-frequency) surgical procedures
What this could lead to
If successful, this could provide a better surgical option for patients with recurrent nasopharyngeal carcinoma, potentially improving survival and reducing complications.
What could go wrong
This is a single-center trial with no blinding, and the results may not apply to all patients. The procedures are invasive and carry risks like bleeding or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECURRENT NASOPHARYNGEAL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Sun Yat-sen University Cancer Center

    RECRUITING

    Guangzhou, Guangdong, 510060, China

  • The Fifth Affiliated Hospital of Sun Yat-sen University

    RECRUITING

    Zhuhai, Guangdong, 519000, China

  • The Nanchang Affiliated Hospital, Sun Yat-Sen University (Nanchang First Hospital)

    RECRUITING

    Nanchang, Jiangxi, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.